ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells

Cancer Res. 2010 Jun 1;70(11):4676-86. doi: 10.1158/0008-5472.CAN-09-4197. Epub 2010 May 18.

Abstract

Cancer stem cells have been hypothesized to explain tumor plasticity, including the capability to adopt distinct differentiation commitments. Among the mechanisms of tumor neovascularization, the ability of some malignant cells to mimic an endothelial phenotype has been recognized by a capacity to form matrix-enriched pseudovascular structures. In addition to the expression of genes associated with an endothelial nature, the molecular dynamism of specific microenvironments may also be critical. Here, we report the identification of the extracellular protease ADAMTS1 as a critical molecule for tumor cells to acquire endothelial-like properties. In a fibrosarcoma model, ADAMTS1 increased tumor growth rate in an angiogenesis-independent manner, influencing the tumor cells to display an exclusive endothelial-like gene signature. We documented the relevant expression of ADAMTS1 in aggressive and highly plastic melanoma and Ewing sarcoma cells. Notably, inhibiting ADAMTS1 action compromised the endothelial mimetic attributes observed in this setting. Our findings provide insights into how the tumor microenvironment can elicit endothelial mimicry by tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / antagonists & inhibitors
  • ADAM Proteins / biosynthesis*
  • ADAM Proteins / metabolism
  • ADAMTS1 Protein
  • Animals
  • Cell Line, Tumor
  • Endothelial Cells / enzymology
  • Endothelial Cells / pathology
  • Fibrosarcoma / enzymology
  • Fibrosarcoma / pathology
  • Humans
  • Melanoma / enzymology*
  • Melanoma / pathology*
  • Mice
  • Mice, Inbred BALB C
  • Phenotype
  • Sarcoma, Ewing / enzymology*
  • Sarcoma, Ewing / pathology*
  • Transplantation, Heterologous

Substances

  • ADAM Proteins
  • ADAMTS1 Protein
  • ADAMTS1 protein, human